Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04265534
What this trial is testing

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 40
Testing effectiveness (Phase 2)WithdrawnNCT00936832
What this trial is testing

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Federation Francophone de Cancerologie Digestive
Early research (Phase 1)Study completedNCT01407224
What this trial is testing

Assessing Cost and Effectiveness of Training and Supervision of Front Line Workers on Early Breastfeeding Practices

Who this might be right for
Malnutrition
Eminence 1,200
Testing effectiveness (Phase 2)Study completedNCT01762202
What this trial is testing

Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.

Who this might be right for
B-cell Lymphoid LeukemiaYoung Patients
Gruppo Italiano Malattie EMatologiche dell'Adulto 80
Large-scale testing (Phase 3)Study completedNCT03061812
What this trial is testing

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Who this might be right for
Small Cell Lung Cancer
AbbVie 444
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Not applicableNot Yet RecruitingNCT06962176
What this trial is testing

Posterior Mitral Isthmus Line With Vein of Marshall Ethanolisation Compared With Anterior Mitral Lines in Patients With Persistent Atrial Fibrillation

Who this might be right for
Persistent Atrial Fibrillation
AZ Sint-Jan AV 146
Not applicableLooking for participantsNCT07003308
What this trial is testing

Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis

Who this might be right for
Ptosis, Eyelid
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 54
Testing effectiveness (Phase 2)UnknownNCT05772624
What this trial is testing

Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma

Who this might be right for
Safety IssuesEfficacy, Self
Hospital Universitario Dr. Jose E. Gonzalez 16
Not applicableEnded earlyNCT00663819
What this trial is testing

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses

Who this might be right for
Rectal CancerUlcerative ColitisFamilial Adenomatous Polyposis+1 more
W.L.Gore & Associates 258
Testing effectiveness (Phase 2)Looking for participantsNCT06510309
What this trial is testing

Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma

Who this might be right for
LymphomaMarginal Zone LymphomaMZL
Gottfried von Keudell, MD PhD 33
Not applicableStudy completedNCT06551532
What this trial is testing

"Ecological Program Changes Pelvic Kinematics in Soccer Players: Pilot Study on Hamstring Injury Implications"

Who this might be right for
Anterior Pelvic TiltSprint Kinematics
RX2 Sports and Health 17
Not applicableUnknownNCT06259773
What this trial is testing

The Roles of MRI, DYNEELAX and Stress X-ray in First-Line Diagnosis of Cruciate Ligament Injury

Who this might be right for
Knee InjuriesAnterior Cruciate Ligament InjuriesKnee Ligament Injury+1 more
Kaohsiung Veterans General Hospital. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06695741
What this trial is testing

Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia

Who this might be right for
Severe Aplastic AnemiaCyclophosphamide Reduced-doseImmunosuppressive Therapy
Institute of Hematology & Blood Diseases Hospital, China 75
Testing effectiveness (Phase 2)Ended earlyNCT03733691
What this trial is testing

Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
Oncotherapeutics 19
Not applicableStudy completedNCT01699217
What this trial is testing

Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

Who this might be right for
Chronic Phase Philadelphia PositiveBCR-ABL PositiveChronic Myeloid Leukaemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Large-scale testing (Phase 3)Temporarily pausedNCT00892346
What this trial is testing

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT02162719
What this trial is testing

A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors

Who this might be right for
Breast Neoplasms
Genentech, Inc. 124
Not applicableStudy completedNCT02217657
What this trial is testing

SmartTouch Catheter for Left Anterior Line - SmarT Line Study

Who this might be right for
Persistent Atrial Fibrillation
LMU Klinikum 75
Testing effectiveness (Phase 2)Study completedNCT00061464
What this trial is testing

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 48
Next Page